Response of the erythron and erythropoietin to autologous blood donations in paediatric subjects. Is erythropoietin supplement necessary?

Vox Sanguinis

Volumn 73, Issue 1, 1997, Pages 24-27

  Han, P ^a   Stacy, D ^a  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; FERRITIN; HEMOGLOBIN; IRON; TRANSFERRIN;

ADOLESCENT; ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD DONOR; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; ERYTHROCYTE; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; IRON METABOLISM; MALE; PRIORITY JOURNAL; RETICULOCYTE COUNT; SCHOOL CHILD; SPINE SURGERY; TRANSFERRIN BLOOD LEVEL;

EID: 0030755774     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1423-0410.1997.7310024.x     Document Type: Article

References (14)

1. Brennan MT, Barabara JA: Transfusion-transm mitted disease. Curr Opinion Hematol 1993;2:320-329.
2. Anderson KC, Weinstein HJ: Transfusion-associated graft-versus-host disease. N Engl J Med 1990;323:315-321.
3. Class FH, Smeenk RJT, Schmidt R, van Steenbrugge GJ, Fernisse JG: Alloimmunisation against the MHC antigens platelet transfusion is due to contaminating leukocytes in the platelet suspension. Exp Haematol 1981;9:84-89.
4. Kickler TS, Spanish JL: Effect of repeated whole blood donations on serum immunoreactive erythopoietin levels in autologous donors. JAMA 1988;260:65-67.
5. Goodnough LT, Wasman J, Corlucci K, Chernosky A: Limitations to donating adequate autologous blood prior to elective orthopedic surgery Arch Surg 1989;124:494-496.
6. Goodnough LT, Rudnick S, Price TH, Ballas SK, Collins ML, Crowley JP, Kosmin M, Kruskall MS, Lenes BA, Menitov JE, Silverstein LE, Smith KJ, Wallas CH, Abels R, Von Tress M: Increased properative collection of autolo- gous blood with recombinant human erythropoietin therapy. N Engl J Med 1989;321:1163-1168.
7. Mercurialli F, Zanella, Barosi G, Inghilleri G, Biffi E, Vinci A, Colotti MT: Use of erythropoietin to increase the volume of autologous blood donated by orthopedic patients. Transfusion 1993;33:55-60.
8. Messmer K: Proceedings of the roundtable of experts in surgrry blood management. Semin Haematol 1996;33(suppl 2):1-80.
9. Goodnough LT, Price TH, Friedman KD,Johnston M, Ciavarella D, Khan N, Sacher R, Vogler WR, Wissel M, Abels RI: A phase III trial of recombinant human erythropoietin therapy in nonanemic orthopedic patients subjected to aggressive removal of blood for autologous use: Dose, response, toixicity and efficacy. Transfusion 1994;34:66-71.
10. Lee LG, Chiu LA: Thiazole orange: A new dye for reticulocyte analysis. Cytometry 1988;7:508-517.
11. Goodnough LT, Price TH, Rudnick S, Soegiarso RW: Preoperative red cell production in patients undergoing aggresive autologous blood phlebotomy with and without erythropoietin therapy. Transfusion 1992;32:441-445.
12. Cook JD, Skikne BJ, Lynch SR, Reusser ME: Estimates of iron sufficiency in the US population. Blood 1986;68:726-731.
13. Widmann FK: Standards for Blood Banks and Transfusion Service, ed. 12. Arlington. American Association of Blood Banks, 1991, p 45
14. Biesma DH, Kraaijenhagen RJ, Poortman J, Marx JJM, VandeWiel A: The effect of oral iron supplementation on erythropoiesis in autologous blood donors. Transfusion 1992;32:162-165.